Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
72 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
- Memorial Medical Center
Springfield, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Saint Vincent Oncology Center
Indianapolis, Indiana, United States
- Medical Oncology and Hematology Associates-West Des Moines
Clive, Iowa, United States
- Mercy Cancer Center-West Lakes
Clive, Iowa, United States
- Iowa Lutheran Hospital
Des Moines, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Iowa-Wide Oncology Research Coalition Ncorp
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Des Moines
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Mercy Medical Center-West Lakes
West Des Moines, Iowa, United States
- Methodist West Hospital
West Des Moines, Iowa, United States
- Menorah Medical Center
Overland Park, Kansas, United States
- Saint Luke'S South Hospital
Overland Park, Kansas, United States
- Kansas City Nci Community Oncology Research Program
Prairie Village, Kansas, United States
- Medstar Franklin Square Medical Center/weinberg Cancer Institute
Baltimore, Maryland, United States
- Michigan Cancer Research Consortium Ccop
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Oakwood Hospital and Medical Center
Dearborn, Michigan, United States
- Saint John Hospital and Medical Center
Detroit, Michigan, United States
- Genesys Regional Medical Center-West Flint Campus
Flint, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Allegiance Health
Jackson, Michigan, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Sparrow Hospital
Lansing, Michigan, United States
- Saint Mary Mercy Hospital
Livonia, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2009
- Primary completion
- 31 Jan 2016
- Completion
- 31 Jan 2016
- Last update posted
- 23 Jul 2019
- Registered enrollment
- 54
- Registry id
- NCT01011933
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.